Pravastatin Sodium, an Inhibitor of HMG-CoA Reductase, Decreases HDL Cholesterol by Transfer of Cholesteryl Ester from HDL to VLDL in Japanese White Rabbits-Reference-Cited by-同舟云学术

Pravastatin Sodium, an Inhibitor of HMG-CoA Reductase, Decreases HDL Cholesterol by Transfer of Cholesteryl Ester from HDL to VLDL in Japanese White Rabbits

Published:2004 Issue:1 Volume:11 Page:22-28
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Miyazaki Atsuhiro¹,Koieyama Tadashi²,Shimada Yukio³,Kikuchi Takashi⁴,Ito Kayoko⁵,Kasanuki Naomi²,Koga Teiichiro⁶

Affiliation:

1. Clinical Development Department, Sankyo Co., Ltd.

2. Pharmacology and Molecular Biology Research Laboratories, Sankyo Co., Ltd.

3. Research Administration Department Research Laboratories, Sankyo Co., Ltd.

4. Intellectual Property Department, Sankyo Co., Ltd.

5. Research Information Department, Sankyo Co., Ltd.

6. Biomedical Research Laboratories, Sankyo Co., Ltd.

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/11/1/11_1_22/_pdf

Reference23 articles.

1. (1) Serizawa N, Nakagawa K, Hamano K, Tsujita Y, Terahara A, and Kuwano H: Microbial hydroxylation of ML-236B (compactin) and monacolin K (MB-530B). J Antibiot (Tokyo), 36: 604−607, 1983

2. (2) Serizawa N, Serizawa S, Nakagawa K, Furuya K, Okazaki T, and Terahara A: Microbial hydroxylation of ML-236B (compactin). Studies on microorganisms capable of 3-beta-hydroxylation of ML-236B. J Antibiot (Tokyo), 36: 887−891, 1983

3. (3) Koga T, Shimada Y, Kuroda M, Tsujita Y, Hasegawa K, and Yamazaki M: Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Biochim Biophys Acta, 1045: 115−120, 1990

4. (4) Koga T, Fukuda K, Shimada Y, Fukami M, Koike H, and Tsujita Y: Tissue selectivity of pravastatin sodium, lovastatin and simvastatin. The relationship between inhibition of de novo sterol synthesis and active drug concentrations in the liver, spleen and testis in rat. Eur J Biochem, 209: 315−319, 1992

5. (5) Koga T, Kikuchi T, Miyazaki A, and Koike H: Tissue-selective inhibition of sterol synthesis in mice by pravastatin sodium after a single or repeated oral administrations. Lipids, 30: 775−779, 1995

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and biological activity of fibrate-based acyl- and alkyl-phenoxyacetic methyl esters and 1,2-dihydroquinolines;Medicinal Chemistry Research;2020-01-26

2. Effects of hydrophilic statins on renal tubular lipid accumulation in diet-induced obese mice;Obesity Research & Clinical Practice;2013-09

3. Dyslipidemia after renal transplantation: A cause for concern?;Pediatric Transplantation;2008-11

4. Prospective monitoring of lipid profiles in children receiving pravastatin preemptively after renal transplantation;Pediatric Transplantation;2005-12

5. Molecular docking of the highly hypolipidemic agent α-asarone with the catalytic portion of HMG-CoA reductase;Bioorganic & Medicinal Chemistry Letters;2005-02